Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Mar;29(3):971-973.
doi: 10.1111/cns.14072. Epub 2023 Jan 4.

A case report of atypical ethylmalonic encephalopathy with peripheral neuropathy

Affiliations
Case Reports

A case report of atypical ethylmalonic encephalopathy with peripheral neuropathy

Guan-Qing Wang et al. CNS Neurosci Ther. 2023 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

FIGURE 1
FIGURE 1
MRI and genetic observations in a patient with ethylmalonic encephalopathy. (A) T2‐weighted, T2 fluid‐attenuated inversion recovery, diffusion‐weighted MR, and associated apparent diffusion coefficient MR of axial images of brain MRI show hyperintensities in the bilateral putamen (red arrows). (B) Sequence electropherogram of c.488G>A and c.475G>C (gray rectangles) variations in the patient from the father and mother, respectively.

Similar articles

References

    1. Tiranti V, D'Adamo P, Briem E, et al. Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. Am J Human Genet. 2004;74(2):239‐252. - PMC - PubMed
    1. Govindaraj P, Parayil Sankaran B, Nagappa M, et al. Child neurology: ethylmalonic encephalopathy. Neurology. 2020;94(12):e1336‐e1339. - PubMed
    1. Tiranti V, Viscomi C, Hildebrandt T, et al. Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. Nat Med. 2009;15(2):200‐205. - PubMed
    1. Ersoy M, Tiranti V, Zeviani M. Ethylmalonic encephalopathy: clinical course and therapy response in an uncommon mild case with a severe ETHE1 mutation. Mol Genet Metabolism Rep. 2020;25:100641. - PMC - PubMed
    1. Di Meo I, Auricchio A, Lamperti C, Burlina A, Viscomi C, Zeviani M. Effective AAV‐mediated gene therapy in a mouse model of ethylmalonic encephalopathy. EMBO Mol Med. 2012;4(9):1008‐1014. - PMC - PubMed

Substances

Supplementary concepts